Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from MedPal AI Plc ( (GB:MPAL) ).
MedPal AI has raised approximately £378,870 through its At-The-Market equity issuance facility by issuing 6.2 million new shares at an average price of 6.11p, bringing total proceeds from the programme to about £877,095 out of a potential £2 million. The fresh capital is earmarked to bolster working capital for its online pharmaceutical arm MedPal Limited, enabling higher stock levels, broader product lines, and marketing to grow the MedPal Pharmacy and Medpal.clinic businesses, with management highlighting the transaction as evidence of investor confidence and noting continued month-on-month growth across its app, pharmacy, and clinic operations; the new shares are expected to be admitted to trading on AIM on or around 22 January 2026, lifting the company’s issued share capital to 433.6 million shares and updating the base for shareholder disclosure thresholds.
More about MedPal AI Plc
MedPal AI plc is a UK-based digital health company specialising in AI-driven wellness management. Its core app aggregates data from more than 100 wearables and health apps to provide non-clinical, personalised lifestyle guidance via an AI wellness coach, and it is developing conversational AI for real-time health insights and recommendations. Through its subsidiary MedPal Limited, the company operates a 24/7 AI-powered automated pharmacy distribution centre offering nationwide NHS and private prescription services, supported by robotic dispensing and AI triage, and is pursuing B2B licensing and partnerships with employers, healthcare providers, and gyms to expand its reach.
Average Trading Volume: 1,099,597
Technical Sentiment Signal: Strong Sell
For a thorough assessment of MPAL stock, go to TipRanks’ Stock Analysis page.